Effect of atropine sulfate in pulmonary hypertrophic osteoarthropathy
Open Access
- 1 July 1980
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 23 (7) , 822-824
- https://doi.org/10.1002/art.1780230708
Abstract
A 49-year-old patient with pulmonary hypertrophic osteoarthropathy was treated with 0.4 mg of atropine sulfate every 4 hours for 14 days. A good clinical response was obtained as measured by handgrip strength, range of motion, and quantitative thermography. Chemical vagotomy supports the hypothesis of the vagal reflex as the pathophysiological mechanism in pulmonary hypertrophic osteoarthropathy.Keywords
This publication has 4 references indexed in Scilit:
- Cancer and arthritisArthritis & Rheumatism, 1967
- REVERSAL OF PULMONARY HYPERTROPHIC OSTEOARTHROPATHY BY VAGOTOMYThe Lancet, 1956
- ARTICULAR MANIFESTATIONS IN PULMONARY DISEASESJAMA, 1954
- BRONCHIAL CARCINOMA PRESENTING AS ARTHRALGIAActa Medica Scandinavica, 1952